MetaModix's Series A Round

MetaModix raised a round of funding on June 19, 2015. Investors include Antipodean Advisors.

Metamodix is dedicated to reducing the human and financial costs of Type 2 Diabetes. The company is developing a drug-free, nonsurgical therapy with the goal of eliminating symptoms and reducing weigh…

Articles about MetaModix's Series A Round: